Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06372470
Status:
RECRUITING
Last Update Posted:
2024-04-23
First Post:
2024-04-15
Brief Title:
Personalised Dose Optimisation of Zestril Supported by the Digital Blood Pressure Diary in a Primary Care Environment in England Pragmatic Observational Pilot Study for Remote Hypertension Treatment
Sponsor:
Closed Loop Medicine
Organization:
Closed Loop Medicine
Study Overview
Official Title:
Personalised Dose Optimisation of Zestril Supported by the Digital Blood Pressure Diary in a Primary Care Environment in England Pragmatic Observational Pilot Study for Remote Hypertension Treatment
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
OptiZest
Brief Summary:
A pragmatic observational proof-of-concept study which aims to determine the feasibility of a remote titration clinic assisted by home blood pressure monitoring and digital solutions and assess its impact on real-world outcomes By incorporating home blood pressure monitoring the study seeks to offer a promising solution for personalised drug titration and self-management potentially enhancing patient outcomes while optimising Zestril utilisation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None